Rhythm Pharmaceuticals (RYTM) EPS (2017 - 2026)
Rhythm Pharmaceuticals (RYTM) EPS from Mar 31, 2017 to Mar 31, 2026. The TTM Rhythm Pharmaceuticals (RYTM) EPS is -$3.04. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Rhythm Pharmaceuticals (RYTM) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +12.17% |
| 3 Years TTM | -2.60% |
| 5 Years TTM | +17.00% |
| All Time TTM | +3.71% |
Annual EPS change of Rhythm Pharmaceuticals (RYTM)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.81 | -72.20% |
| 2025 | -$2.92 | -29.98% |
| 2024 | -$4.18 | +34.41% |
| 2023 | -$3.11 | -2.86% |
| 2022 | -$3.20 | +131.10% |
| 2021 | -$1.38 | -54.30% |
| 2020 | -$3.03 | -5.30% |
| 2019 | -$3.20 | +48.62% |
| 2018 | -$2.15 | +74.20% |
| 2017 | -$1.24 | -51.30% |
| 2016 | -$2.54 | N/A |
Comparison Rhythm Pharmaceuticals (RYTM) five years EPS CAGR with competitors
Rhythm Pharmaceuticals (RYTM) five years EPS CAGR is 17.00%.